| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5681519 | Medicine - Programa de Formación Médica Continuada Acreditado | 2017 | 4 Pages |
Abstract
In spondyloarthropathy-related dactylitis the treatment is based on NSAIDs, local physical measures and infiltrations. Both synthetic and biological DMARDs have been used and new biological (Ustekinumab, Secukinumab) and non-biological (Apremilast) drugs have been approved.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
A. Turrión Nieves, R. MartÃn Holguera, C. Bohorquez Heras, A. Movasat Hadjkan,